Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (USDHHS)
Street 1: 1600 Clifton Road (E-10)
Street 2:
City: Atlanta
Province: Georgia
Post Code: 30333
Country: United States of America
Phone: 4046398120
Email: pgl5@cdc.gov
Web Site: http://www.cdc.gov/nchstp/tb

Focal Point Contact Information

Salutation: Dr
First Name: Philip
Last Name: LoBue
Title: Director, CDC/ Division of Tuberculosis Elimination
Email: pgl5@cdc.gov
Phone:  

Alternate Focal Point Contact Information

Salutation: Dr
First Name: Philip
Last Name: LoBue
Title: Director, CDC/ Division of Tuberculosis Elimination
Email: pgl5@cdc.gov
Phone:  

General Information

Board Constituency: Technical agencies
Organization Type - Primary: Governmental Organization
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
The Division of Tuberculosis Elimination at CDC/USDHHS is the equivalent of the National Tuberculosis Control Program for the United States. We coordinate national research and program activities with other federal organizations in the United States (e.g., Food and Drug Administration, National Institutes of Health) through the Federal Tuberculosis Task Force, and with local and state tuberculosis programs through the National Tuberculosis Controllers Association. Additionally, in response to epidemiologic trends in the United States and recommendations by the U.S. Institute of Medicine, our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR).

CDC is one of the founding members of the STOP TB Partnership, and remains committed to the global prevention and control of tuberculosis.
 
Total number of staff in your organization: 6 - 10
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? Unable to disclose amount
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
CDC is the national TB programme in the US.
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
United States of America

Specializations

Delivery of health services and care
Funding, including innovative and optimized approach to funding TB Care
Research and Development
Technical Assistance

Specializations in Countries

Delivery of health services and care United States of America
Funding, including innovative and optimized approach to funding TB Care United States of America
Technical Assistance United States of America

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR).

Drug-Resistant TB:
Our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR).

TB-HIV:
Our agency provides technical support to global tuberculosis control effors by focusing on expanding access to DOTS in high-burden countries, by sharing lessons gained through the unprecedented 1985-1992 resurgence of tuberculosis and multidrug resistant TB (DOTS-plus), and to improve control of TB/HIV as part of the President's Emergency Plan for AIDS Relief (PEPFAR).

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date:  
Last updated: August 18, 2014